CFB and endometrial endometrioid carcinoma: Moreover, in contrast to serous tumors, where increased inhibin βB immunostaining or mRNA levels are associated with reduced survival [14, 16], neither inhibin βA nor βB expression levels are associated with survival in endometrioid endometrial carcinomas [12, 13].